Colt A. Egelston

City Of Hope National Medical Center — United States

Medicine · Health Sciences

19h-index1.7kcitations154works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(108), Immunotherapy and Immune Responses(57), Immune cells in cancer(28), Cancer, Stress, Anesthesia, and Immune Response(26), Ferroptosis and cancer prognosis(18)

Publications154 total

Divergent oncogenic signaling and immune microenvironment changes in low-grade serous ovarian cancer patients undergoing intraperitoneal chemotherapy
npj Precision Oncology·2025Open Access
Dietary fiber intake improves survival in allogeneic HCT patients and exhibits synergistic effects with taurine supplementation in preclinical models
Blood·2025Open Access
75 Next-generation multiplex IF enabled by the superior amplification and universal antibody compatibility of HCR™ HiFi Encoders
Regular and Young Investigator Award Abstracts·2025Open Access
Abstract P2-05-24: Impact of the gut microbiome on immune-related adverse events (irAE) in HR+/HER2- locally advanced or metastatic breast cancer (MBC) patients (pts) receiving palbociclib, endocrine therapy, and pembrolizumab
Clinical Cancer Research·2025
Abstract 7164: Predictive biomarkers and immune dynamics in MSS metastatic colorectal cancer treated with regorafenib, ipilimumab, and nivolumab
Cancer Research·2025
Abstract A004: Neoantigen Vaccine for Neoadjuvant Therapy of Pancreatic Cancer
Cancer Immunology Research·2025
Abstract A105: Induction of an anti-tumor immune response following intratumoral injection of oncolytic virus CF33-hNIS-antiPD-L1 in patients with metastatic triple negative breast cancer (mTNBC)
Cancer Immunology Research·2025
Abstract A038: Inducing tumor associated tertiary lymphoid structures using cellular therapy
Cancer Immunology Research·2025
Interim report on engineered NK cell trial in lung cancer refractory to immune checkpoint inhibitors
JCI Insight·2025· 7 citedOpen Access
A First-in-Human Dose Escalation Clinical Trial of Engineered Natural Killer Cell Therapy in Non-Small Cell Lung Cancer Patients Refractory to Immune Check Point Inhibitors
Blood·2024
Supplementary Figure 14 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Table 3 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Figure 15 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Table 4 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Figure 8 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Figure 5 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Figure 4 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Table 1 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Table 2 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Figure 16 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
page 1 of 8Next →

Frequent Co-authors

Peter P. Lee(29), Weihua Guo(17), Susan E. Yost(13), Yuan Yuan(13), Diana L. Simons(12), Christian Avalos(11), James Waisman(11), Joanne Mortimer(8), Paul Frankel(7), Daniel Schmolze(7), Christopher Ruel(6), Jin Sun Lee(6), Aileen Tang(6), Norma Martínez(6), Marwan Fakih(6), Jian Ye(6), Stephen J. Forman(5), Shawn T. Solomon(5), Yinghui Huang(5), Chongkai Wang(5)